Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Interim Management Statement

7 May 2014 12:33

RNS Number : 4757G
Mandarin Oriental International Ltd
07 May 2014
 

To: Business Editor For immediate release

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

7th May 2014 ‒ Mandarin Oriental International Limited has today issued its Interim Management Statement covering the period from 1st January to 6th May 2014.

 

The trading performance across the Group during the period was broadly stable. In Asia, the results of the Hong Kong and Singapore hotels remained steady, while Bangkok continued to be affected by challenging conditions. Europe benefited from further stabilization of the Paris hotel and improvement in Geneva, which more than offset softer demand in London. In The Americas, while the majority of hotels increased their average rates, the overall performance was impacted by lower demand in Washington when compared to the same period last year, which included the 2013 Presidential Inauguration.

 

In March, the Group entered into an agreement with a local development partner to expand its wholly-owned hotel in Munich. A mixed-use complex is to be constructed on an adjacent site that will include a hotel element in which the Group will have a freehold interest. The Group's total projected investment in the complex, which is due to open in 2021, is estimated at €124 million (US$170 million) in today's terms, and will include a refurbishment of the existing hotel's rooms.

 

During the period, a new management contract was announced for a 121-room luxury resort located on Bali's southern peninsula, scheduled to open in 2017. The Group has ceased management of two unbranded hotels; the Grand Lapa hotel in Macau in January and the Elbow Beach hotel in Bermuda in March.

 

Two new hotels are scheduled to open within the next six months, in Taipei, Taiwan and in Bodrum, Turkey.

 

The Group's financial position remains healthy, with net debt remaining in line with that reported at 31st December 2013.

 

On 8th April 2014 shareholders approved the transfer of the Company's share listing on the Main Market of the London Stock Exchange to the standard segment from the premium segment. The transfer is expected to become effective on 27th May 2014.

 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the most luxurious hotels, resorts and residences. Having grown from a well-respected Asian hotel company into a global brand, the Group now operates, or has under development, 44 hotels representing close to 11,000 rooms in 25 countries, with 20 hotels in Asia, ten in The Americas and 14 in Europe, Middle East and North Africa. In addition, the Group operates or has under development, 13 Residences at Mandarin Oriental connected to its properties. Mandarin Oriental International Limited is incorporated in Bermuda and has its primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

Hamish Ross (852) 2895 9288

Sally de Souza (852) 2895 9167

 

GolinHarris

Kennes Young (852) 2501 7987

 

This and other Group announcements can be accessed through the internet at 'www.mandarinoriental.com'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFDLFBZEFXBBL
Date   Source Headline
27th Jul 201210:53 amRNSJC&C 2012 Half Year Financial Statements
27th Jul 201210:21 amRNSHalf Yearly Report
26th Jul 201211:20 amRNSAstra 2012 Half Year Financial Statements
28th Jun 201211:01 amRNSNotice of 2012 Half-Yearly Results
11th Jun 201210:15 amRNSDirector Declaration
31st May 201211:34 amRNSTotal Voting Rights
16th May 201210:24 amRNSDirector/PDMR Shareholding
11th May 201210:08 amRNSAdditional Listing
10th May 20123:39 pmRNSAGM Statement
10th May 20123:36 pmRNSResult of AGM
10th May 201212:34 pmRNSInterim Management Statement
3rd May 201211:15 amRNSAnnual Information Update
2nd May 201210:17 amRNSDividend
27th Apr 201210:12 amRNSDirector Declaration
25th Apr 201210:52 amRNSJC&C Q1 Results
25th Apr 201210:47 amRNSAstra First Quarter Results
23rd Apr 201210:41 amRNSDividend
11th Apr 201210:16 amRNSAnnual Financial Report
2nd Apr 201210:43 amRNSDirector Declaration
27th Mar 201210:12 amRNSCirc re. Scrip Dividend Scheme
2nd Mar 20129:06 amRNSFinal Results
29th Feb 20129:36 amRNSJC&C Full Year Financial Results 2011
27th Feb 201210:25 amRNSAstra 2011 Full Year Financial Statements
6th Feb 20129:32 amRNSNotice of 2011 Final Results
15th Dec 201110:36 amRNSShares Purchase
14th Dec 201111:04 amRNSShares Purchase
2nd Dec 201111:34 amRNSShares Purchase
9th Nov 20119:15 amRNSInterim Management Statement
1st Nov 20119:30 amRNSJC&C 3rd Quarter Financial Results
31st Oct 201110:30 amRNSTotal Voting Rights
31st Oct 201110:15 amRNSAstra 2011 3rd Quarter Financial Statements
12th Oct 201111:48 amRNSDirector/PDMR Shareholding
6th Oct 201110:28 amRNSAdditional Listing
3rd Oct 201110:21 amRNSDirector Declaration
29th Sep 201111:09 amRNSDirectorate Change
28th Sep 201110:24 amRNSDividend
26th Sep 201111:22 amRNSDividend
21st Sep 201112:00 pmRNSShares Purchase
20th Sep 201111:01 amRNSShares Purchase
31st Aug 201110:11 amRNSCirc re. Scrip Dividend Scheme
29th Jul 201110:14 amRNSJC&C 2011 Half Year Financial Statements
29th Jul 201110:13 amRNSHalf Yearly Report
28th Jul 201110:26 amRNSAstra 2011 Half Year Financial Results
30th Jun 201110:21 amRNSNotice of 2011 Half-Yearly Results
20th Jun 20117:00 amRNSShares Purchase
17th Jun 201111:55 amRNSHolding(s) in Company
8th Jun 201111:56 amRNSShares Purchase
3rd Jun 201111:18 amRNSShares Purchase
31st May 201110:33 amRNSTotal Voting Rights
31st May 20117:00 amRNSShares Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.